Cannabis News

Cannabis News Moving Markets April 22, 2019 – CannTrust, MedMen, Supreme Cannabis

Today’s Headlines

-CannTrust Holdings Inc (TSE:TRST) (NYSE:CTST) releases preliminary financials; public offering
-MedMen (CNSX:MMEN) (OTCMKTS:MMNFF) changes to executive team
-MJardin Group (CNSX:MJAR) (OTCMKTS:MJARF) enters into definitive agreement for Carson City Agency Solutions
-Supreme Cannabis Company (TSE:FIRE) (OTCMKTS:SPRWF) announced launch of Cambium subsidiary
-Cannabis One Holdings Inc (CNSX:CBIS) (OTCMKTS:CAAOF) executes 3 definitive agreements in Nevada
-Fire & Flower (CVE:FAF) (OTCMKTS:FFLWF) granted two additional Alberta licenses
-FSD Pharma Inc (CNSX:HUGE) (OTCMKTS:FSDDF) subsidiary receives sales license
-The Green Organic Dutchman (TSE:TGOD) (OTCMKTS:TGOWF) receives oil sales license
-High Tide Ventures Inc (CNSX:HITI) (OTCMKTS:HTDEF) closes first tranche of convertible debentures
-Nextleaf (CNSX:OILS) announce financing
-TILT Holdings (CNSX:TILT) (OTCMKTS:SVVTF) announce subsidiary Jupiter Research LLC California expansion
-Zenabis Global Inc (CVE:ZENA) (OTCMKTS:ZBISF) graduating to TSX

Midas Letter News features the most important headlines in the cannabis industry. Producer Ricki Gurwitz brings viewers the latest breaking news from the cannabis, mining, technology, and crypto industries. This daily segment highlights the acquisitions, announcements, and deals trending in the space.

************************

Check out our website:

Home

************************

SUBSCRIBE to our YouTube:
http://bit.ly/MidasLetterYoutube

SUBSCRIBE to our 2nd YouTube Channel – Midas Letter Clips:
https://bit.ly/2rtQzgy

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter:
http://bit.ly/MidasLetterTwitter

Like Us on Instagram:
http://bit.ly/MidasLetterInsta

Like Us on Facebook:
http://bit.ly/MidasLetterFacebook

************************

#WeedStocks
#MidasLetter

banner

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *